Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Healthy Eating and Active Lifestyle After Bowel Cancer: HEAL ABC (HEALABC)

11 octobre 2022 mis à jour par: Jana Sremanakova, University of Manchester

Healthy Eating and Active Lifestyle After Bowel Cancer - HEAL ABC Workbook: Development and Feasibility Trial

Trial Design:

This is a feasibility randomised controlled trial.

Aim:

The study aims to test the Healthy Eating and Active Lifestyle After Bowel Cancer - HEAL ABC intervention and HEAL ABC resources for feasibility and will inform a future definitive randomised controlled trial (RCT).

Objectives:

  1. Is it practical to run HEAL ABC study as a definitive randomised controlled trial?
  2. Adherence to intervention, motivations, barriers and facilitators of CRC survivors to follow HEAL ABC.

Study Population:

Colorectal cancer survivors who completed surgery and/or active treatment.

Intervention:

The intervention group will use HEAL ABC resource with supportive telephone calls every two weeks during the intervention period and once a month during the follow up period.

Control:

Participants follow standard care recommendations.

Timing and duration:

3 months intervention with 6 months follow up period

Aperçu de l'étude

Statut

Complété

Intervention / Traitement

Description détaillée

Background:

Investigators were awarded a grant to develop a lifestyle resource called HEAL ABC - the Healthy Eating and Active Lifestyle After Bowel Cancer. This resource is based on prevention guidelines of World Cancer Research Fund and American Institute of Cancer Research. The resource was developed in cooperation with a psychologist and so has incorporated behaviour change theory. Investigators organised focused groups with patients and healthcare professionals, and amended the resource based on their feedback.

In this study, investigators will test the HEAL ABC resource and the HEAL ABC intervention for its practicality before further studies will be conducted.

HEAL ABC consists of 10 booklets and supportive materials. The order for using the booklets is not specified. Participants will be assigned their first booklet based on the one they perceive to be the easiest for setting an incremental goal and achieving it. This means the participant starts with the booklet of the highest self-efficacy and after the participant achieves successful behaviour change, he or she can move more confidently to the next booklet. During the follow up period, participants will use the follow up booklet which helps them to continue with changes they have made and encourage them to set a new goals.

Participants in the intervention group will receive a supportive telephone call every two weeks during the intervention period (three months) and once a month during the six months follow up.

Participants allocated to the control group will given information about publicly available resources on healthy lifestyle recommendations. No additional support will be provided.

Primary Question/Objective:

Is it feasible to run a definitive RCT to determine the effectiveness of HEAL ABC? This study will address questions around suitability and practicality of using the HEAL ABC resource and the ability to run an intervention in relation to adherence, recruitment, retention rates and the ability to collect relevant data.

Secondary Question/Objective:

Adherence to intervention and the motivations, barriers and facilitators of CRC survivors to follow HEAL ABC.

Type d'étude

Interventionnel

Inscription (Réel)

35

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Manchester, Royaume-Uni, M13 9WL
        • Manchester University NHS Foundation Trust
      • Manchester, Royaume-Uni, M139PL
        • The University of Manchester
    • Great Manchester
      • Manchester, Great Manchester, Royaume-Uni, M6 8HD
        • Salford Royal NHS Foundation Trust

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Adults, age ≥18
  • Minimum 12 weeks post-surgery and/or active treatment
  • Completed all active anti-cancer treatments, including surgery, radiotherapy or chemotherapy
  • Body mass index ≥20 kg/m2 and no previous unintentional weight loss ≥5% of body weight in the previous six months.
  • Identified as living an unhealthy lifestyle based on current recommendations - follow less than four of the WCRF/AICR recommendations on eligibility questionnaire
  • Ability to work with computer, smart phone or tablet.
  • Able to give informed consent.

Exclusion Criteria:

  • Receiving treatment for malignancy.
  • Secondary malignancy.
  • Having short bowel syndrome, Crohn's disease, ulcerative colitis, diverticulitis or jejunostomy (due to requirement for a very specific diet).
  • Previous stroke, congested cardiac failure or oedema.
  • Hepatic or renal failure
  • Less than 12 weeks post-surgery or active treatment.
  • Meeting the requirements of a healthy lifestyle (follow four or more of the WCRF/AICR recommendations).
  • Being on any therapeutic diets, multiple food intolerances or allergies.
  • Unplanned weight loss of ≥10% in the previous 3-6 months.
  • Cannot read or communicate in English (due to resource constraints of this PhD study).

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: HEAL ABC
Participants allocated to the intervention will be encouraged to follow the HEAL ABC resources in order to make a healthy eating and active lifestyle change. This will be achieved by setting specific goal(s) and by making concrete plan(s) to implement changes in their everyday life. Interventions will be delivered in the form of written resources that will guide participants. Supportive phone calls using motivational interviewing techniques will be provided to participants every two weeks to encourage lifestyle changes.
Participants will be assigned their first booklet based on the one they perceive to be the easiest for setting an incremental goal and achieving it. After the participant achieves successful behaviour change, he or she can move more confidently to the next booklet. Support will be provided every two weeks over the phone for 12 weeks. During the follow-up period, participants will use the follow-up booklet which helps them to continue with changes they have made and encourage them to set new goals.
Aucune intervention: HEALTH
Participants allocated to the control group will be referred to publicly available resources on healthy lifestyle recommendations but will not receive any additional support.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Adherence to intervention
Délai: 3 months
Assessed as adherence to WCRF/AICR guidelines by using a scoring system for nutrition and physical activity guideline adherence developed by McCullough and colleagues. Number of goals set and number of changes implemented in everyday life during the 3 months intervention.
3 months
Adherence to intervention
Délai: 6 months
Assessed as adherence to WCRF/AICR guidelines by using a scoring system for nutrition and physical activity guideline adherence developed by McCullough and colleagues. Number of goals set and number of changes implemented in everyday life during the 6 months follow up.
6 months
Recruitment rates
Délai: 3 months
Cumulative recruitment against target rate each month.
3 months
Recruitment rates
Délai: 6 months
Cumulative recruitment against target rate each month.
6 months
Retention rates
Délai: 3 months
Calculated as the number of participants who completed the study divided by the number of participants randomised.
3 months
Retention rates
Délai: 6 months
Calculated as the number of participants who completed the study divided by the number of participants randomised.
6 months
Acceptability of the intervention
Délai: 3 months
This will be qualitatively assessed through in depth interviews with a subset of the trial participants.
3 months
Acceptability of the intervention
Délai: 6 months
This will be qualitatively assessed through in depth interviews with a subset of the trial participants.
6 months
Data completion rates
Délai: 3 months
Completeness of collected data will be assessed for all time points (% missing).
3 months
Data completion rates
Délai: 6 months
Completeness of collected data will be assessed for all time points (% missing).
6 months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change in participants' experience, motivation, barriers and facilitators to use HEAL ABC resources and follow the intervention
Délai: 3 months and 6 months
Qualitatively assessed with in depth interviews.
3 months and 6 months
Change in behaviour
Délai: Baseline, 3 months and 6 months
The health action process approach (HAPA) questionnaires, previously used in publications investigating changes in HAPA constructs in lifestyle interventions. A 5 point Likert scale will be used for each question. Minimum score is 15 and maximum score is 75. Higher score is better score.
Baseline, 3 months and 6 months
Change in dietary intake
Délai: Baseline, 3 months and 6 months
Three day dietary assessment. Participants will complete prospectively food diary during the day and enter all foods and drinks consumed into online system for dietary assessment - INTAKE24.
Baseline, 3 months and 6 months
Change in BMI
Délai: Baseline, 3 months and 6 months
Body weight [kg] and height [m] to calculate body mass index
Baseline, 3 months and 6 months
Change in waist to hip ratio
Délai: Baseline, 3 months and 6 months
waist circumference [cm] and hip circumference [cm] to calculate waist to hip ratio
Baseline, 3 months and 6 months
Change in body composition (BIA)
Délai: Baseline, 3 months and 6 months
lean mass [%] and fat mass [%] using bio-impedance machine
Baseline, 3 months and 6 months
Change in body composition (CT scan)
Délai: Baseline, 3 months and 6 months
muscle mass [cm2] and fat mass [cm2]using CT scans body composition analysis
Baseline, 3 months and 6 months
Change in physical activity
Délai: Baseline, 3 months and 6 months
Global Physical Activity Questionnaire is used to assess the metabolic equivalent (MET) based on Global Physical Activity Questionnaire Analysis Guide: https://www.who.int/ncds/surveillance/steps/resources/GPAQ_Analysis_Guide.pdf
Baseline, 3 months and 6 months
Change in step count
Délai: Baseline, 3 months and 6 months
pedometer
Baseline, 3 months and 6 months
Patients' socio-demographic characteristics
Délai: Baseline
age, gender, marital status, occupation, education, income, ethnicity, smoking status and number of supplements used
Baseline
Contact with primary and secondary healthcare services
Délai: 6 months
The Healthcare Resource Use Questionnaire - questionnaire was developed by a health economist for the EU funded project 'PreventIT' (2016-2018, grant number 689238) responding to the Horizon 2020, Personalised Health and Care call PHC-21: Advancing active and healthy aging with ICT: Early risk detection and intervention. There is no set score - questionnaire is used to estimate the costs associated with different healthcare services used.
6 months
Mortality
Délai: 6 months
Patient's medical records
6 months
Morbidity
Délai: 6 months
Patient's medical records
6 months
Change in Quality of life
Délai: Baseline, 3 months and 6 months
SF-12 questionnaire - 12 questions, total score can range from 0 to 100 (sore zero indicates the lowest level of health and 100 indicates the highest level of health).
Baseline, 3 months and 6 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Jana Sremanakova, University of Manchester

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Liens utiles

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

30 janvier 2021

Achèvement primaire (Réel)

30 septembre 2022

Achèvement de l'étude (Réel)

30 septembre 2022

Dates d'inscription aux études

Première soumission

9 décembre 2019

Première soumission répondant aux critères de contrôle qualité

10 janvier 2020

Première publication (Réel)

13 janvier 2020

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

12 octobre 2022

Dernière mise à jour soumise répondant aux critères de contrôle qualité

11 octobre 2022

Dernière vérification

1 octobre 2022

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

Investigators have published detailed study protocol and will share further details in main study publications

Délai de partage IPD

Study protocol has been published and is available online

Critères d'accès au partage IPD

free access

Type d'informations de prise en charge du partage d'IPD

  • PROTOCOLE D'ÉTUDE

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner